Mari McQuitty
Impact in
- Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 5
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Hemoglobinopathies and Related Disorders 1
-
- Kruppel-like factors research 4
- Co-authors
- Claire Harrison (5 shared papers)Haifa Kathrin Al‐Ali (5 shared papers)Viktoriya Stalbovskaya (5 shared papers)Jean‐Jacques Kiladjian (5 shared papers)Heinz Gisslinger (4 shared papers)Tiziano Barbui (4 shared papers)Francisco Cervantes (3 shared papers)Alessandro M. Vannucchi (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Journal of Clinical Oncology (1 paper)Blood Pressure (1 paper)New England Journal of Medicine (1 paper)Leukemia (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Mari McQuitty
11 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Genetics 1.7k
- Hematology 1.3k
- Rheumatology 587
- Molecular Biology 1.0k
- Oncology 220
Countries citing papers authored by Mari McQuitty
This map shows the geographic impact of Mari McQuitty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari McQuitty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari McQuitty more than expected).
Fields of papers citing papers by Mari McQuitty
This network shows the impact of papers produced by Mari McQuitty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari McQuitty. The network helps show where Mari McQuitty may publish in the future.
Co-authors
The 25 scholars most cited alongside Mari McQuitty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis Hit paper breakdown → | 2012 | 1218 |
| 2 | Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis Hit paper breakdown → | 2016 | 350 |
| 3 | 2013 | 294 | |
| 4 | 1997 | 91 | |
| 5 | 2002 | 55 | |
| 6 | 2015 | 35 | |
| 7 | 2000 | 26 | |
| 8 | 2011 | 22 | |
| 9 | 2003 | 21 | |
| 10 | 2000 | 21 | |
| 11 | 2002 | 2 |
About Mari McQuitty
Mari McQuitty is a scholar working on Genetics, Molecular Biology, Surgery, Hematology and Psychiatry and Mental health, having authored 11 papers that have together received 2.1k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Kruppel-like factors research (4 papers), Epilepsy research and treatment (2 papers), Antimicrobial Resistance in Staphylococcus (1 paper), Hemoglobinopathies and Related Disorders (1 paper), Pharmacological Effects and Toxicity Studies (1 paper), Analytical Methods in Pharmaceuticals (1 paper) and Blood Pressure and Hypertension Studies (1 paper). The work is most often cited by research in Genetics (1.7k citations), Hematology (1.3k citations), Rheumatology (587 citations), Molecular Biology (1.0k citations) and Oncology (220 citations). Mari McQuitty has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Claire Harrison, Haifa Kathrin Al‐Ali, Viktoriya Stalbovskaya, Jean‐Jacques Kiladjian, Heinz Gisslinger, Tiziano Barbui, Francisco Cervantes, Alessandro M. Vannucchi, Giovanni Barosi and Deborah Hunter. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, Blood Pressure, New England Journal of Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.